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Background:  The aims of the study were to determine the accuracy of fluorodeoxyglucose positron emission to-
mography (FDG-PET) in detecting pulmonary metastasis through video-assisted thoracoscopic surgery (VATS), a 
technique that allows the excisional biopsy of small pulmonary nodules in patients with known malignancies. 
Materials and Methods: Between October 2007 and April 2010, 28 patients with known malignancies and small 
pulmonary nodules underwent VATS excisional biopsies. All patients were in follow-up for a previously treated 
malignancy. The malignancies included the following: colorectum (9), breast (6), head and neck (5), stomach (3), 
lymph (1), ovary (1), uterus (1), bladder (1), and liver (1). Results: There were 16 men and 12 women whose 
mean age was 56.7 years old (range, 38 to 77 years). The sizes of the mean nodules removed were 11.3 mm 
(range, 7 to 21 mm). Diagnoses included metastatic (11), bronchioloalveolar carcinoma (1), primary adenocarcinoma 
(1), pulmonary tuberculosis (6), fibrosis (5), organizing pneumonia (3), lymphoid hyperplasia (1). Among these le-
sions, 46.4% were malignant. Conclusion: True positive FDG-PET was 39.2%. FDG-PET is not a sensitive test in 
the evaluation of patients with a history of an extrathoracic malignancy and newly diagnosed small pulmonary 
nodules. VATS excision allows the early diagnosis of small pulmonary nodules, with low morbidity, in patients with 
known malignancies.
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INTRODUCTION
During  follow-up,  patients  with  known  malignancies  com-
monly  undergo  screening  studies  to  detect  recurrence  or 
metastasis.  18F-fluorodeoxyglucose  positron  emission  tomog-
raphy  (FDG-PET)  is  increasingly  being  used  for  screening, 
often  in  conjunction  with  computed  tomography  (CT).
Overall,  in  the  setting  of  an  indeterminate  nodule  greater 
than 1 cm, FDG-PET has a sensitivity of 96.8% and specific-
ity of 77.8% in the detection of malignancy [1]. However, lit-Hong Kyu Lee, et al
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Table 1. Patient characteristics
Characteristics Number
Sex
Male
Female
Known  malignancies
Colorectum
Breast
Head  and  neck
Stomach
Lymph
Ovary
Uterus
Bladder
Liver
16
12
 9
 6
 5
 3
 1
 1
 1
 1
 1
tle is known about the accuracy of FDG-PET in detecting ex-
trathoracic  malignancies  that  have  spread  to  the  lungs. 
Recently,  video  assisted  thoracoscopic  surgery  (VATS)  has 
been  performed  for  the  resection  of  small  pulmonary  lesions. 
This  technique  is  less  painful  and  invasive,  and  is  thus  more 
acceptable  to  patients  than  thoracotomy.
In  this  study,  we  performed  VATS  in  cases  of  suspected 
pulmonary  metastasis  from  known  malignancy.  The  aims  of 
the study were to determine the accuracy of FDG-PET in de-
tecting  pulmonary  metastasis  through  the  VATS  technique, 
which  allows  the  excisional  biopsy  of  small  pulmonary  nod-
ules  in  patients  with  known  malignancies.
MATERIALS AND METHODS
Between  July  2007  and April 2010, we prospectively stud-
ied  28  patients  who  were  in  follow-up  care  for  a  previously 
treated malignancy. The malignancies included the colorectum 
(9),  breast  (6),  head  and  neck  (5),  stomach  (3),  lymph  (1), 
o v a r y ,  u t e r u s ,  l i v e r ,  b l a d d e r  ( T a b l e  1 ) .  S m a l l  p u l m o n a r y  n o d -
ules  had  been  found  on  chest  CT  and  FDG-PET  during  rou-
tine follow-up care. Diagnostic VATS was then performed as 
part of a metastatic evaluation within a mean 20 days (range, 
2  to  90  days).
Medical records were reviewed for age, gender, primary tu-
mor  type,  chest  CT,  and  FDG-PET  results,  as  well  as  histo-
pathology  of  the  removed  nodules.  Chest  CT  results  were 
transcribed  based  on  the  clinical  report,  as  well  as  review  of 
the  images,  with  nodule  measurement.  FDG-PET  imaging  re-
sults  with  the  maximum  standardized  uptake  values 
(SUVmax)  were  abstracted  from  the  radiology  reading  at  our 
institution.
In  operating  room,  the  patient  was  positioned  for  VATS. 
The  operative  lung  was  isolated.  After  prepping  and  draping, 
three working ports were created and the lung was visualized. 
An  autosuture  stapling  device  that  was  45  or  60  mm  long 
and  used  4.8  mm  staples  was  placed  on  an  area  of  the  lung 
with palpation and was fired. The excised wedge of lung was 
removed  from  the  chest. Palpation  confirmed the  resection of 
the  correct  pulmonary  nodule.  Frozen  section  histopathologic 
evaluation identified the nature of the lesion. The independent 
sample  t-test  was  used  for  statistical  analysis.  All  statistical 
analyses  were  performed  using  SPSS  ver.  18.0  (SPSS  Inc., 
C h i c a g o ,  I L ,  U S A ) .
RESULTS
There were 16 men and 12 women whose median age was 
56.7  years  old  (range,  38  to  77  years).  All  lesions  were  re-
sected  on  the  first  attempt  using  standard  VATS  wedge  ex-
cision  techniques.  Postoperative  median  length  of  chest  tube 
drainage was 3.9 days (range, 2 to 8 days). No intraoperative 
or  postoperative  complications  were  detected.
Thirteen  of  28  (46.4%)  small  pulmonary  nodules  were 
malignant.  The  histopathology  of  the  nodules  was  metastatic 
adenocarcinoma  in  6  (5  in  the  colorectum,  1  in  the  breast), 
primary  adenocarcinoma  in  1  (breast),  squamous  cell  in  4  (3 
i n  t h e  h e a d  a n d  n e c k ,  1  i n  t h e  u t e r u s ) ,  u r o t h e l i a l  c a r c i n o m a  
in  1,  and  bronchioloalveolar  carcinoma  in  1.  Benign  diag-
noses included pulmonary tulberculosis in 6, fibrosis in 5, or-
ganizing  pneumonia  in  3,  and  lymphoid  hyperplasia  in  1 
(Table  2).
Overall sensitivity of 18F-FDG-PET in the 28 patients who 
underwent  resection  was  39.2%.  No  association  was  found 
b e t w e e n  m a li g n a n t  a n d  b e n ig n  t i s s u e  i n  th e  S U V m a x  a n d  t u -
mor sizes (Table 3). A receiver operating characteristics curve 
was  constructed  and  a  cut-off  value  was  determined  for  the 
diagnosis  of  metastatic  small  pulmonary  nodules.  Using  the 
cut-off of  2.5 for  the SUVmax, the sensitivity and specificity 
for  predicting  metastatic  small  pulmonary  nodules  were Detecting Pulmonary Metastasis with FDG-PET through Video-assisted Thoracoscopic Surgery
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Table 2. Results of video-assisted thoracoscopic surgery
Valiables Number
Malignant
Metastatic
Bronchioloalveolar  carcinoma
Primary  adenocarcinoma
Benign
Pulmonary  tuberculosis
Fibrosis
Organizing  pneumonia
Lymphoid  hyperplasia
11
 1
 1
 6
 5
 3
 1
Table 3. Tumor size and maximal SUV (mean)
Valiables Benign Malignant p-value
Tumor  size  (mm)
Maximal  SUV
11.88
 3 . 7 5
10.81
 4 . 1 8
0.565
0.649
SUV=standard  uptake  value.
Fig. 1. Receiver operating characteristics (ROC) curve for maximal 
standard uptake value (95% confidence interval). 
Fig. 2. Receiver operating characteristics (ROC) curve for tumor 
size (95% confidence interval). 
60.0%  and  43.7%,  respectively.  Using  the  cut-off  of  1  mm 
for  tumor  size,  the  sensitivity  and  specificity  for  predicting 
metastatic  small  pulmonary  nodules  were  45.0%  and  50.0%, 
respectively  (Figs.  1,  2).
DISCUSSION
The  presumed  diagnosis  of  small  pulmonary  nodules  is 
based  on  several  factors:  the  age  of  the  patient,  associated 
symptoms,  appearance  o f  t h e  l e s i o n  o n  a  r a d i o g r a p h ,  a n d  t h e  
length  of  time  the  lesion  has  been  present.  A  single  pulmo-
nary  nodule  is  more  likely  to  be  malignant  in  patients  with 
known  cancer  [2]. 
The idea of whole body cancer surveillance is very appeal-
ing  and  has,  for  some,  compelled  the  use  of  FDG-PET  as  a 
screening  tool  for  recurrence  of  various  malignancies. 
Integrated  FDG-PET/CT  can  evaluate  nodules  as  small  as  7 
or 8 mm in size. A high SUVmax, especially in a small pul-
monary  nodule,  provides  important  information  and  helps 
guide  therapy.  Moreover,  an  integrated  FDG-PET/CT  may 
provide  other  targets  (lymph  nodes  or  M1  sites)  that  harbor 
metastatic  disease  that  require  biopsy  prior  to  resection.  The 
optimal  value  of  the  SUVmax  for  mediastinal  and  hilar 
lymph  nodes  has  recently  been  evaluated  [3].
The  usefulness  of  18F-FDG-PET  for  differentiation  of  be-
nign  and  malignant  pulmonary  lesions  has  been  investigated 
in various studies [4-6]. The reported sensitivity and specific-
ity  of  the  18F-FDG-PET  ranges  between  0.75  and  1.0. 
SUVmax  were  significantly  increased  in  malignant  lesions 
compared  to  benign  lesions  [7],  and  the  value  of  2.5  is  ac-
cepted  as  the  cut-off  point  for  malignancy  [8].
SUV  expresses  FDG  uptake  by  the  lesion  normalized  ac-
cording  to  the  dose  administered  and  the  subject’s  body 
weight.  In  fact,  having  defined  the  many  factors  that  can  af-
fect the uptake of labeled glucose and, therefore, the SUV, it 
is  not  easy  to  establish  fixed  values  that  serve  to  distinguish Hong Kyu Lee, et al
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between  the  benign  and  malignant  nature  of  a  small  pulmo-
nary  nodule  [9].  A  number  of  formulas  designed  to  correct 
the  underestimation  of  the  SUV  caused  by  hyperglycemia, 
such as adjusting the value of this parameter according to the 
patient’s  serum  glucose  level,  have  also  been  studied.  Using 
this  method,  some  authors  have  achieved  a  slight  increase  in 
the  reproducibility  of  the  technique  [10].  While  much  has 
been  published  about  the  sensitivity  of  FDG-PET  for  pulmo-
nary  nodules  in  primary  lung  cancer,  little  information  has 
been  available  on  the  sensitivity  of  PET  for  metastatic  pul-
monary  lesions  from  extrathoracic  malignancies.
Modern  CT  scanners  have  a  far  higher  detection  rate  than 
CT scanners of 15 years ago. Even in the case of small nod-
ules,  we  could  use  CT  localization  to  identify  the  metastasis. 
The  accurate  and  timely  diagnosis  of  pulmonary  nodules  is 
essential  for  the  proper  management  of  patients  with  known 
malignancies.  The  implications  of  metastatic  lung  lesions,  no 
matter what size, on treatment selection for patients who have 
received a diagnosis of a malignancy are enormous. However, 
the  small  size  of  these  lesions  makes  diagnosis  difficult. 
Definitive  diagnosis  of  lung  lesions  can  sometimes  not  be 
made  because  of  the  inaccessibility  of  the  true  lesion  or  the 
inadequacy  of  the  sample  size  [11,12].  Bronchoscopic  biopsy 
and percutaneous needle biopsy under CT are useful methods; 
however,  they  are  not  always  able  to  yield  a  definite  diag-
nosis,  since  results  depend  on  the  technique  and  tumor  size. 
Moreover,  specimens  may  be  too  small  to  be  diagnosed,  and 
negative  biopsy  results  might  require  further  examination. 
Surgical lung biopsy is considered the final diagnostic modal-
ity  to  be  used  in  patients  with  undiagnosed  small  pulmonary 
nodules.
VATS  has  replaced  thoracotomy  as  the  preferred  surgical 
modality  for  diagnostic  excisional  biopsy  of  indeterminate 
pulmonary  nodules  because  of  decreased  morbidity.  We  do 
use  finger  palpation  through  the  port  if  we  have  difficulty 
identifying  the  lesion  or  the  margins.  We  also  use  long 
Roberts  haemostatic  clamps  to  feel  the  surface  of  the  lung 
when  we  search  for  the  lesion.  It  is  generally  accepted  that 
VATS  biopsy  reduces  postoperative  pain  and disability,  caus-
es fewer operative scars, and is equally effective in obtaining 
histologic  diagnosis  [13,14].
CONCLUSION
In  patients  with  a  history  of  an  extrathoracic  malignancy 
and  newly  diagnosed  small  pulmonary  nodules,  FDG-PET  is 
not  sensitive  enough  to  dictate  treatment.  The  results  of  this 
study  in  patients  with  known  malignant  disease  reinforce  the 
need  for  timely  VATS  wedge  excision  of  small  pulmonary 
nodules.
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